Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model

J Craniomaxillofac Surg. 2010 Sep;38(6):423-30. doi: 10.1016/j.jcms.2010.01.003. Epub 2010 Mar 1.

Abstract

Introduction: Angiogenesis and mesenchymal stem cells (MSCs) promote osteogenesis. The aim of the present study was to evaluate whether bone morphogenetic protein (BMP-7) promoted osteoinduction could be enhanced by combining it with vascular endothelial growth factor (VEGF) or MSCs in highly porous biphasic calcium phosphate (BCP) ceramics.

Materials and methods: BCP ceramic blocks were implanted in an ectopic site in 24 mice (BMP-7 vs. BMP-7/VEGF; BMP-7 vs. BMP-7/MSCs and BMP-7 vs. Control; each group n=8). Specimens were analysed 12 weeks after surgery by environmental scanning electron microscopy (ESEM) and Giemsa staining.

Results: In all implanted scaffolds, newly formed bone was observed, even in the control site. No statistical differences in the amount of new bone were found in the presence of BMP-7 compared to BMP-7/VEGF (p=1.0) or BMP-7/MSCs (p=0.786). ESEM revealed a degradation of the scaffolds. A higher degradation was observed in areas where no bone-implant contact was present compared to areas where the ceramic was integrated in newly formed bone.

Conclusions: Neither VEGF nor MSCs enhanced BMP-7 induced bone formation under the selected conditions. The present ceramic seemed to be osteoinductive and degradable, making this material suitable for bone tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants*
  • Animals
  • Bone Morphogenetic Protein 7 / pharmacology*
  • Calcium Phosphates / chemistry*
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Drug Combinations
  • Durapatite
  • Mesenchymal Stem Cell Transplantation*
  • Mice
  • Mice, Inbred C57BL
  • Multipotent Stem Cells / transplantation
  • Osteogenesis / drug effects*
  • Tissue Scaffolds*
  • Vascular Endothelial Growth Factor A / pharmacology*

Substances

  • Bone Morphogenetic Protein 7
  • Calcium Phosphates
  • Drug Combinations
  • Vascular Endothelial Growth Factor A
  • beta-tricalcium phosphate
  • Durapatite